(Q41032565)

25 September 2017

title

An increasing number of calcium oxalate stone events worsens treatment outcome (English)

1 reference

25 September 2017

1 reference

Parks JH

1

1 reference

25 September 2017

Coe FL

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

25 September 2017

1 reference

25 September 2017

volume

45

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

1722-1730

1 reference

Prevention and treatment of kidney stones. Role of medical prevention

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

The medical aspects of urolithiasis: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Should patients with single renal stone occurrence undergo diagnostic evaluation?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Observations on the analysis of ten thousand urinary calculi

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Hyperparathyroidism in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

The Renal Clearance of Oxalate in Normal Subjects and Patients with Primary Hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Evidence that Increased Circulating 1α,25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in Sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Hypercalciuria and Hyperuricosuria in Patients with Calcium Nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Is selective therapy of recurrent nephrolithiasis possible?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

A urinary calcium-citrate index for the evaluation of nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Calcium nephrolithiasis and medullary sponge kidney in women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Nephrolithiasis during Pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

The Natural History of Calcium Urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Allopurinol treatment of uric-acid disorders in calcium-stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Hyperuricosuric calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

The pathogenesis and treatment of kidney stones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Determination of citrate with citrate lyase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

An improved colorimetric procedure for urine oxalate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Bone mineral content in patients with calcium urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Abnormal Bone Histology in Idiopathic Hypercalciuria *

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.224

7 January 2021

Identifiers

DOI

10.1038/KI.1994.224

1 reference

Dimensions Publication ID

25 September 2017

1011781419

0 references

1 reference